Journal Club - Recent Additions

May - 2021

Previous Next    

Showing Journal 7 of 10

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

I Rosas, N Brau, M Waters et al New Eng J Med, 2021, 384:1503-1516


Interleukin-6 is released in response to infection and stimulates inflammatory pathways as part of the acute-phase response. Tocilizumab is a monoclonal antibody that inhibits both membrane-bound and soluble interleukin-6 receptors and are used to...


Previous Comments

No Comments yet.